CELL MARQUE Trilogy™
- Analysis ID
- AKL 10204320458
- Risk classification
- Kelas Resiko : A
- Product class
- Kelas : 1
- Registration date
- Aug 30, 2023
- Expiry date
- Dec 31, 2026
- Product type
- Reagents and Specimen ProvidersGeneral purpose reagent.Invitro Diagnostics
- Manufacturer
- CELL MARQUE CORPORATION
- Country of origin
- United States
- Authorized representative
- PT. VANTAGEBIO SCIENTIFIC SOLUTION
- AR address
- GREEN SEDAYU BIZPARK CAKUNG GS-9A NO. 12, JL. CAKUNG CILINCING KM2 JAKARTA TIMUR
CELL MARQUE Trilogy™ is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 10204320458. The device is manufactured by CELL MARQUE CORPORATION from United States, and is classified as Risk Class Kelas Resiko : A. The authorized representative in Indonesia is PT. VANTAGEBIO SCIENTIFIC SOLUTION.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.